Menu
Back to Journals » Therapeutics and Clinical Risk Management » Volume 16
Review
Tildrakizumab: An Evidence-Based Review of Its Use in the Treatment of Moderate-to-Severe Chronic Plaque Psoriasis
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 6,695 | Dovepress* | 5,106+ | 926 | 6,032 | |
| PubMed Central* | 1,589 | 278 | 1,867 | ||
| Totals | 6,695 | 1,204 | 7,899 | ||
| *Since 24 September 2020 | |||||
View citations on PubMed Central and Google Scholar